CharlesW. M.RobertsMDPhD
Pediatric Hematology & Oncology • Memphis, TNCancer Center Director and EVP, St. Jude Children's Research Hospital
Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1995 - 1997
Washington University in St. Louis School of MedicineClass of 1995
Certifications & Licensure
TN State Medical License 2016 - 2025
MA State Medical License 1997 - 2016- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Publications & Presentations
PubMed
- 8 citationsChromatin remodellers as therapeutic targets.Hayden A Malone, Charles W M Roberts
Nature Reviews. Drug Discovery. 2024-09-01 - PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression.Priya Mittal, Jacquelyn A Myers, Raymond D Carter, Sandi Radko-Juettner, Hayden A Malone
Nature Communications. 2024-08-24 - Author Correction: Developmental origins shape the paediatric cancer genome.Xiaolong Chen, Wentao Yang, Charles W M Roberts, Jinghui Zhang
Nature Reviews. Cancer. 2024-07-01
Press Mentions
- Mithramycin Induces Promoter Reprogramming and Differentiation of Rhabdoid TumorDecember 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
